National Bank of Canada’s Centessa Pharmaceuticals CNTA Stock Holding History

National Bank of Canada’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-25	Closed	-$993	–	3162
2026 Q1	$993	Hold	25	–	–	﹤0.01%	2674
2025 Q4	$625	Buy	+25	New	+$633	﹤0.01%	2672
2025 Q3	–	Sell	-1,600	Closed	-$21K	–	2910
2025 Q2	$21K	Buy	1,600 +1,000	+167%	+$12.7K	﹤0.01%	2164
2025 Q1	$8.62K	Hold	600	–	–	﹤0.01%	2273
2024 Q4	$10.1K	Buy	+600	New	+$9.94K	﹤0.01%	2329

National Bank of Canada's CNTA Position: Q2 2026 in Review

National Bank of Canada sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 25 shares — an estimated $993 sold.

National Bank of Canada first reported a position in CNTA in Q4 2024 and held it in 5 quarters. The position peaked at $21K in Q2 2025. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

National Bank of Canada reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
National Bank of Canada sold 25 Centessa Pharmaceuticals shares in Q2 2026, an estimated $993.
National Bank of Canada first reported a position in Centessa Pharmaceuticals in Q4 2024 and held it in 5 quarters.
National Bank of Canada's Centessa Pharmaceuticals position peaked at $21K in Q2 2025.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.